Rifampicin ($RIF)

Overview

Rifampicin ($RIF) market snapshot: Price $0.00019719, market capitalization $197.12K, and reported 24-hour volume $106.

Trading activity: Reported 24-hour volume equals 0.05% of market capitalization. The local markets snapshot lists Raydium and Raydium (CLMM) among venues with observed trading activity.

YearBull indicators: YearBull Rank #4,690. Bull Score 46/100. YB Market Risk Low. This relative market-volatility label is not an investment-safety assessment. Cycle Early. Observed price change: 24h -0.57% · 7d -9.25% · 30d -23.73%.

Values are descriptive and should be read together rather than as a price forecast. Read the YearBull methodology. Snapshot date: 2026-10-27. Data history: 90 days available in the latest 90-day window.

Methodology responsibility: YearBull’s analytical methodology and presentation rules are developed and maintained by Alan Zelvin, Founder & Lead Crypto Researcher. This note identifies responsibility for the methodology; it does not attribute authorship of this data snapshot.

What is Rifampicin ($RIF)?

Source description

“$RIF token represents longevity experiments performed with the compound Rifampicin. These experiments are live-streamed on Pump Science. What is Pump Science? Pump Science is a gamified longevity research platform. Users can speculate on life-extending compounds, stream live experiment data, and submit your own longevity cocktails for testing on model organisms. What is Rifampicin? Rifampicin is traditionally known as an antibiotic, but it’s been gaining attention for its surprising effects on aging. In tiny organisms like C. elegans (a model organism often used in aging research), Rifampicin has been shown to activate the cell’s natural defense mechanisms against stress and damage. Imagine it as a sort of "cellular coach," encouraging cells to stay healthy and resilient by protecting against harmful oxidative stress and maintaining the quality of proteins within the cell. These protective effects help the worms live longer and healthier lives. While it’s still early days, and we don’t yet know if Rifampicin can do the same in humans, its ability to promote cellular health makes it an exciting area of research in the quest for anti-aging therapies​.”

This source-supplied description may contain old, promotional, or unverified claims and is not YearBull editorial analysis.

Rifampicin ($RIF) project facts

  • Source tags: Solana Ecosystem, Meme, Decentralized Science (DeSci), Solana Meme, Pump.fun Ecosystem, Pump Science Ecosystem, Binance Alpha Spotlight
  • Recorded networks: Solana

Official links and contract records appear in Key Facts. Project details can change, so verify current information with the project.

Rifampicin ($RIF) FAQ

How are $RIF’s longevity experiments presented to participants?

The project states that $RIF represents longevity experiments involving Rifampicin, with the experiments live-streamed on Pump Science. This presentation is intended to let participants follow experiment activity and data as it unfolds, rather than treating the token solely as a static digital asset. The project does not specify the experimental protocol, study duration, measurement standards, or independent validation process.

What role does Pump Science play in the $RIF ecosystem?

Pump Science is presented as a gamified longevity research platform connected to $RIF’s experiments. According to the project, users can speculate on life-extending compounds, view live experiment data, and submit their own longevity cocktails for testing on model organisms. The project does not specify how submissions are reviewed, how experiments are selected, or how participation affects token holders.

Why is Rifampicin being studied in relation to aging?

Rifampicin is traditionally known as an antibiotic, but the project highlights reported effects in the model organism C. elegans. It says the compound may activate natural cellular defenses against stress and damage, including mechanisms associated with oxidative-stress protection and protein-quality maintenance. These claims concern early-stage model-organism research; the project explicitly says it is not yet known whether comparable effects occur in humans.

What biological mechanisms does the project associate with Rifampicin?

The project describes Rifampicin as potentially encouraging cells to remain resilient by supporting defenses against harmful oxidative stress and helping maintain protein quality. It uses the metaphor of a “cellular coach” to explain this proposed role. These statements describe the project’s interpretation of early research in C. elegans, not an established human treatment or confirmed anti-aging therapy.

Can users submit their own longevity mixtures through Pump Science?

The project says Pump Science allows users to submit their own longevity cocktails for testing on model organisms. This feature positions the platform as participatory as well as observational, although the project does not specify eligibility requirements, testing procedures, safety controls, review criteria, or whether submissions involving human use are permitted. The stated testing context is model organisms rather than people.

Rifampicin metric comparison

This comparison is a stored snapshot generated 2026-10-24 06:30 UTC from 288 daily observations available from 2025-12-30 through 2026-10-24. It is separate from the latest analytical cards above. Percentiles compare the snapshot value with that day's analytical universe; a higher percentile means a larger observed value, not necessarily a better investment characteristic.

MetricSnapshot30d before90d beforeChange vs 30dUniverse percentile
Price$0.00020424$0.00024759$0.00018388-17.5%n/a
Market cap$204.4K$247.5K$183.8K-17.4%P44.8
YearBull Rank#3,212#523#2,619Lower by 2,689P61.9
Bull Score51/10066/10043/100-15.0 ptsP52.3
Turnover0.03%0.95%0.25%-0.9 ptsP20.0
YB Market RiskLowLowLowUnchangedn/a
CycleEarlyEarlyEarlyUnchangedn/a

Median absolute daily movement 2.28%; distance from the highest local daily price -61.2%; circulating supply change 0.0%. These measurements are descriptive and do not predict future direction.

YearBull Rank on this page

Latest available YearBull Rank for rifampicin: #4690.

Rank timeline (last 365 days)

Rank movement (nearest daily data).

Reading rule: smaller rank numbers are better.

  • 7d window (2026-10-20): #2229 → #4690 (down by 2461).
  • 30d window (2026-09-27): #1195 → #4690 (down by 3495).

Liquidity context: liquidity often shows up as how easily the rank holds its gains.

Venue angle: a broader footprint often smooths the rank trajectory.

Stability posture: a stable slope can beat a flashy month.

Cycle read: recent movement can fit a transition rather than a clean trend.

YearBull Rank is an internal ordering on YearBull that positions a coin relative to the rest of the tracked universe. A smaller rank number indicates a stronger position at that moment. It is best read as relative context across time windows, not as a guarantee.

Editorial note: This analysis was prepared by the YearBull research team under the direction of Alan Zelvin, Founder and Lead Crypto Researcher. The assessment follows YearBull’s internal research methodology and editorial standards. Methodology · Editorial Policy
Research context

Related research and comparable assets

All hubs →

Similar coins

ApeBond (ABOND) (ABOND) logoApeBond (ABOND)ABOND$0.00058968#3,817
Purple (PURPLE) logoPurplePURPLE$0.00019764#10,685
The Crypto Dog (DOG) logoThe Crypto DogDOG$0.00019718#7,053
JustOneSui (ONE) logoJustOneSuiONE$0.00021658#8,433

Popular by YearBull Rank

Rifampicin ($RIF) Markets

Stored venue snapshot. Markets last checked: 2026-07-27. Updated on a rolling basis; no fixed refresh date is promised. Venue listings and volumes are stored snapshots, not live quotes.
Exchange Top Pair Stored 24h volume (snapshot) Trust Rank
Raydium $RIF/SOL $1.19K #1,346
Raydium (CLMM) BIO/$RIF $129 #186

Listings are ordered by reported snapshot volume. Trust Rank is an external venue-quality indicator; it is not an endorsement or a solvency guarantee.